SCHEMBL6170367

SCHEMBL6170367

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)CCc2c(Cl)cccc2Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 8/20 0.48
MAPT P10636 5/20 0.48
RAB9A P51151 3/20 0.48
NPC1 O15118 1/20 0.48
PKM P14618 1/20 0.48
CRHBP P24387 1/20 0.48
CRHR2 Q13324 1/20 0.48
AGTR1 P30556 1/20 0.48
HTT P42858 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 3/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
MEN1 O00255 2/20 0.47
TDP1 Q9NUW8 1/20 0.46
PTGER4 P35408 1/20 0.46
GAA P10253 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170745 0.94 KMT2A (0.50) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6170387 0.89 HTT (0.54) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6168808 0.85 KMT2A (0.51) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6169173 0.85 MAPT (0.65) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6170461 0.84 L3MBTL1 (0.53) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6171410 0.84 ALDH1A1 (0.63) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6170391 0.83 KMT2A (0.53) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6169121 0.82 L3MBTL1 (0.48) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6170345 0.82 KMT2A (0.59) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6170738 0.82 KMT2A (0.49) KMT2AALDH1A1MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed